144 related articles for article (PubMed ID: 9713943)
41. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
42. A Comparative Study on the Adverse Reactions of Purified Chick Embryo Cell Vaccine (PCECV) and Purified Vero Cell Rabies Vaccine (PVRV).
Ramezankhani R; Shirzadi MR; Ramezankhani A; Poor Mozafary J
Arch Iran Med; 2016 Jul; 19(7):502-7. PubMed ID: 27362245
[TBL] [Abstract][Full Text] [Related]
43. Safety and immunogenicity of a new chromatographically purified rabies vaccine in comparison to the human diploid cell vaccine.
Arora A; Moeller L; Froeschle J
J Travel Med; 2004; 11(4):195-9. PubMed ID: 15541220
[TBL] [Abstract][Full Text] [Related]
44. Short duration of neutralizing antibody titers after pre-exposure rabies vaccination with suckling mouse brain vaccine.
Zanetti CR; Consales CA; Rodrigues-da-Silva AC; Toyoshima YK; Pereira OA
Braz J Med Biol Res; 1998 Oct; 31(10):1275-80. PubMed ID: 9876298
[TBL] [Abstract][Full Text] [Related]
45. Immunization of dogs with a DNA vaccine induces protection against rabies virus.
Perrin P; Jacob Y; Aguilar-Sétien A; Loza-Rubio E; Jallet C; Desmézières E; Aubert M; Cliquet F; Tordo N
Vaccine; 1999 Oct; 18(5-6):479-86. PubMed ID: 10519937
[TBL] [Abstract][Full Text] [Related]
46. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2.
Müller T; Selhorst T; Burow J; Schameitat A; Vos A
Dev Biol (Basel); 2006; 125():195-204. PubMed ID: 16878477
[TBL] [Abstract][Full Text] [Related]
47. Antibody responses induced by immunization with a Japanese rabies vaccine determined by neutralization test and enzyme-linked immunosorbent assay.
Arai YT; Kimura M; Sakaue Y; Hamada A; Yamada K; Nakayama M; Takasaki T; Kurane I
Vaccine; 2002 Jun; 20(19-20):2448-53. PubMed ID: 12057599
[TBL] [Abstract][Full Text] [Related]
48. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
[TBL] [Abstract][Full Text] [Related]
49. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera.
Thraenhart O; Ramakrishnan K
J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705
[TBL] [Abstract][Full Text] [Related]
50. Post-exposure DNA vaccination protects mice against rabies virus.
Lodmell DL; Ewalt LC
Vaccine; 2001 Mar; 19(17-19):2468-73. PubMed ID: 11257379
[TBL] [Abstract][Full Text] [Related]
51. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
Seroka D
Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
[TBL] [Abstract][Full Text] [Related]
52. Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries.
Bernard KW; Fishbein DB; Miller KD; Parker RA; Waterman S; Sumner JW; Reid FL; Johnson BK; Rollins AJ; Oster CN
Am J Trop Med Hyg; 1985 May; 34(3):633-47. PubMed ID: 4003672
[TBL] [Abstract][Full Text] [Related]
53. Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).
Malerczyk C; Vakil HB; Bender W
Hum Vaccin Immunother; 2013 Jul; 9(7):1454-9. PubMed ID: 23571224
[TBL] [Abstract][Full Text] [Related]
54. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody.
Dietzschold B; Tollis M; Rupprecht CE; Celis E; Koprowski H
J Infect Dis; 1987 Nov; 156(5):815-22. PubMed ID: 3655404
[TBL] [Abstract][Full Text] [Related]
55. Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine.
Vodopija R; Lafont M; Baklaić Z; Ljubicić M; Svjetlicić M; Vodopija I
Vaccine; 1997 Apr; 15(5):571-4. PubMed ID: 9160527
[TBL] [Abstract][Full Text] [Related]
56. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier.
Roy A; Hooper DC
J Virol; 2007 Aug; 81(15):7993-8. PubMed ID: 17507463
[TBL] [Abstract][Full Text] [Related]
57. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.
Moore SM; Ricke TA; Davis RD; Briggs DJ
Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666
[TBL] [Abstract][Full Text] [Related]
58. Genetic Characterization of Human Rabies Vaccine Strain in Japan and Rabies Viruses Related to Vaccine Development from 1940s to 1980s.
Horiya M; Posadas-Herrera G; Takayama-Ito M; Yamaguchi Y; Iizuka-Shiota I; Kato H; Okamoto A; Saijo M; Lim CK
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298707
[TBL] [Abstract][Full Text] [Related]
59. Immune response to purified chick embryo cell culture rabies vaccine manufactured in India.
Natarajan M; Mukundan P; John TJ
Indian J Med Res; 1992 Mar; 95():51-3. PubMed ID: 1601469
[TBL] [Abstract][Full Text] [Related]
60. An immune stimulating complex (ISCOM) subunit rabies vaccine protects dogs and mice against street rabies challenge.
Fekadu M; Shaddock JH; Ekström J; Osterhaus A; Sanderlin DW; Sundquist B; Morein B
Vaccine; 1992; 10(3):192-7. PubMed ID: 1557935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
